Peptide record

TPDB11471

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11471
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 33-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
SVMGTVKDLLIGAGKSAAQSVLKALSCKLSKDC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C142H253N39O45S3
RNEHFPWY
LKS
3322.99
9.65
5
2
14
+3
0.41
0.433
109.39
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
125
0.04
9
Residue Composition
number
4
A
0
R
0
N
2
D
2
C
0
E
1
Q
3
G
0
H
1
I
5
L
5
K
1
M
0
F
0
P
5
S
1
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 2 C: 2 E: 0 Q: 1 G: 3 H: 0 I: 1 L: 5 K: 5 M: 1 F: 0 P: 0 S: 5 T: 1 W: 0 Y: 0 V: 3
Chemical Descriptors
33 reviewed residue count
C142H253N39O45S3 sequence-only estimate (linear, free termini)
3322.99 sequence-only estimate (linear, free termini)
9.65 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.41 sequence-only estimate (linear, free termini)
0.433 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
10.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
10.5 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

IC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
10.5 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

led P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
10.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
10.5 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

IC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
10.5 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

led P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
10.5 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
10.5 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

IC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
10.5 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
10.5 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
10.5 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

IC 10.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
10.5 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 21.0 ug/ml), Gram+ bacteria S. aureus (MIC 10.5 ug/ml), and yeast C. albicans (MIC 10.5 ug/ml). Updated 7/2021